Sign up to save your podcasts
Or
Share Repurposing rheumatology drugs for COVID-19: JAK inhibitors
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Repurposing rheumatology drugs for COVID-19: JAK inhibitors
Marwan Bukhari talks about the rationale behind investigating baricitinib and other JAK inhibitors for the treatment of COVID-19 and outlines the current efficacy data.
View all episodes
By Springer HealthcareMarwan Bukhari talks about the rationale behind investigating baricitinib and other JAK inhibitors for the treatment of COVID-19 and outlines the current efficacy data.